← FDA Drug Approvals (Drugs@FDA)
LASMIDITAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HUMANWELL PHARMACEUTICAL US INC · Approved 2025-12-19
Drug application
- FDA Application #
ANDA219669- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LASMIDITAN
- Generic name
- Lasmiditan
- Active ingredients
- LASMIDITAN
- Dosage form
- TABLET
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- HUMANWELL PHARMACEUTICAL US INC
- First approval
- 2025-12-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown